Cardiac Assist Devices (CAD) Global Market

Cardiac Assist Devices (CAD) Global Market – Forecast To 2027

Publishing Date :	June, 2021
Report Code :	HCMD0155
Price:	Single license $4,950 Site license $6,750 Global license $9,000

Note: The report would be dispatched after confirmation of payment

The heart conditions are considered advanced or end-stage heart failure when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor heart is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The Cardiac assist devices (CAD) i.e., Ventricular Assist Devices (VAD), Total Artificial Heart (TAH), and Intra-Aortic Balloon Pump (IABP) are used to treat various conditions related to the heart such as end-stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis and others. The ventricular assist device is a mechanical pump that supports heart function and blood flow by reducing the workload of the left ventricle, right ventricle, or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body. The indication for VAD use is acute cardiogenic shock (post-cardiac surgery, myocarditis, and massive myocardial infarction) and chronic heart failure. Percutaneous Ventricular Assist Devices (PVADs) to provide hemodynamic support in patients undergoing high-risk percutaneous coronary intervention (PCI). PVADs are often used as temporary support in left ventricular failure patients who are assisted for LVAD implantation. An artificial heart (TAH) is a mechanical assist device for people with biventricular heart failure and heart transplant candidate which replaces both native ventricles and all four chambers of the heart, thereby eliminating the symptoms of cardiac insufficiency or heart failure. Intra-aortic balloon pump (IABP) is placed in the aorta to help the heart to pump more blood by reducing the workload on the heart and improves the function of the left ventricle as this is the chamber that pumps blood into the aorta. IABP is used in conditions such as acute mitral valve regurgitation or severe heart failure, left ventricular failure, unstable angina and others.

According to IQ4I Analysis, the CAD global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $4,813.5 million by 2027. Cardiac Assist Devices based on product type are segmented into Ventricular assist device (VAD), Total Artificial Heart (TAH), and Intra-Aortic Balloon Pump (IABP) among which VAD commanded the largest share in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027. Ventricular assist device is sub-segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), and Biventricular Assist Devices (Bi-VAD). Among this, LVAD commanded the largest revenue in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027. CAD market based on pump type is segmented into Pulsatile Pump and Continuous Flow Pump, among which, continuous flow pump segment commanded the largest share in 2020 and is expected to grow at double digit CAGR from 2020 to 2027. The continuous flow pump is further segmented into axial flow pump and Centrifugal flow pump, the axial flow pump generated the largest revenue in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027. CAD market based on implant type is segmented into Extracorporeal CAD, Intracorporeal CAD, and Percutaneous CAD, among these, percutaneous CAD generated the largest revenue in 2020 and is expected grow at a strong double digit CAGR from 2020 to 2027. CAD market based on patient type is segmented into Adult and Pediatric, among which, adult market commanded the largest revenue in 2020. The CAD application market is classified as Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR), and Bridge to Candidacy (BTC) among which Bridge to recovery (BTR) commanded the largest share in 2020 and is expected to grow at a strong double digit CAGR from 2020 to 2027.

Some of the key players of the Cardiac assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed, Inc (U.S.), Reliant Heart, Inc (U.S.), Fresenius Medical Care AG & Co. KGaA Care AG & Co. KGaA (Germany), Getinge Group (Sweden), Syncardia Systems LLC (U.S.), Zeon Corporation (Japan), Teleflex Incorporated (U.S.) and others.

1 EXECUTIVE SUMMARY
2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY

2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET

3.3.1 DRIVERS AND OPPORTUNITIES

3.3.1.1 INCREASING INCIDENCE OF HEART FAILURE
3.3.1.2 SHORTAGE OF HEART DONORS
3.3.1.3 TECHNOLOGICAL ADVANCEMENTS IN CAD
3.3.1.4 RISING GERIATRIC POPULATION
3.3.1.5 VAST PIPELINE PRODUCTS
3.3.1.6 INCREASE IN FUNDING FOR CAD RESEARCH

3.3.2 RESTRAINTS AND THREATS

3.3.2.1 ADVERSE EVENTS AND COMPLICATION WITH THE IMPLANTATIONS OF CAD
3.3.2.2 COST OF THE DEVICES
3.3.2.3 LACK OF SKILLED AND TRAINED PROFESSIONALS
3.3.2.4 STRINGENT REGULATORY GUIDELINES
3.3.2.5 AVAILABILITY OF ALTERNATIVE PRODUCTS

3.4 REGULATORY AFFAIRS

3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION

3.4.1.1 ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
3.4.1.2 ISO 14644-1 CLEANROOM STANDARDS
3.4.1.3 ISO 13485 MEDICAL DEVICES
3.4.1.4 ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
3.4.1.5 ISO 14971: RISK MANAGEMENT OF MEDICAL DEVICES
3.4.1.6 ISO 14708-5: ACTIVE IMPLANTABLE MEDICAL DEVICES - PART 5: CIRCULATORY SUPPORT DEVICES
3.4.1.7 IEC 60601-1 MEDICAL ELECTRICAL EQUIPMENT STANDARD
3.4.1.8 IEC 60601-1-11 HOME CARE SAFETY

3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 CHINA
3.4.6 JAPAN
3.4.7 INDIA

3.5 REIMBURSEMENT SCENARIO

3.5.1 REIMBURSEMENT TABLE

3.5.1.1 VENTRICULAR ASSIST DEVICE REIMBURSEMENT
3.5.1.2 CAD PHYSICIAN REIMBURSEMENT

3.6 FUNDING SCENARIO
3.7 UPCOMING TECHNOLOGY
3.8 CLINICAL TRIAL DATA
3.9 PATENT TRENDS
3.10 TECHNOLOGICAL ADVANCEMENTS

3.10.1 INTRODUCTION
3.10.2 EXTRA AORTIC BALLOON PUMP
3.10.3 NON-BLOOD-CONTACTING CADS
3.10.4 MUSCLE POWERED VADS

3.11 PORTER’S FIVE FORCE ANALYSIS

3.11.1 THREAT OF NEW ENTRANTS
3.11.2 THREAT OF SUBSTITUTES
3.11.3 BARGAINING POWER OF SUPPLIERS
3.11.4 BARGAINING POWER OF BUYERS
3.11.5 COMPETITIVE RIVALRY

3.12 PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION

3.12.1 U.S. PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
3.12.2 U.K. PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
3.12.3 GERMANY PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
3.12.4 FRANCE PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS
3.12.5 JAPAN PERCUTANEOUS VENTRICULAR ASSIST DEVICE (PVAD) MARKET PENETRATION ANALYSIS

3.13 INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION

3.13.1 U.S. INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
3.13.2 U.K. INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
3.13.3 GERMANY INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
3.13.4 FRANCE INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS
3.13.5 JAPAN INTRA-AORTIC BALLOON PUMP (IABP) MARKET PENETRATION ANALYSIS

3.14 SUPPLY CHAIN ANALYSIS
3.15 MARKET SHARE ANALYSIS BY MAJOR PLAYERS

3.15.1 CARDIAC ASSIST DEVICES (CAD) GLOBAL MARKET SHARE ANALYSIS
3.15.2 VENTRICULAR ASSIST DEVICES (VAD) GLOBAL MARKET SHARE ANALYSIS
3.15.3 INTRA-AORTIC BALLOON PUMP (IABP) GLOBAL MARKET SHARE ANALYSIS

3.16 CARDIAC ASSIST DEVICES NUMBER OF UNITS SOLD BY REGION

3.16.1 VENTRICULAR ASSIST DEVICES NUMBER OF UNITS SOLD BY REGION

3.16.1.1 VENTRICULAR ASSIST DEVICES (VAD) NUMBER OF UNITS SOLD
3.16.1.2 PERCUTANEOUS VENTRICULAR ASSIST DEVICES NUMBER OF UNITS SOLD

3.16.2 IABP DEVICES GLOBAL NUMBER OF UNITS SOLD BY REGION
3.16.3 TOTAL ARTIFICIAL HEART NUMBER OF UNITS BY REGION
3.16.4 COMPANYWISE VAD NUMBER OF UNITS SOLD (2020)

3.17 COMPARISON OF CARDIAC ASSIST DEVICES

4 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PRODUCT

4.1 INTRODUCTION
4.2 VENTRICULAR ASSIST DEVICES (VAD)

4.2.1 LEFT VENTRICULAR ASSIST DEVICES (LVAD)
4.2.2 RIGHT VENTRICULAR ASSIST DEVICES (RVAD)
4.2.3 BI-VENTRICULAR ASSIST DEVICES (BI-VAD)

4.3 INTRA-AORTIC BALLOON PUMPS (IABP)
4.4 TOTAL ARTIFICIAL HEART (TAH)

5 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE

5.1 INTRODUCTION
5.2 EXTRACORPOREAL OR PARACORPOREAL CAD
5.3 INTRACORPOREAL CAD
5.4 PERCUTANEOUS CAD

6 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE

6.1 INTRODUCTION
6.2 PULSATILE FLOW PUMP
6.3 CONTINUOUS FLOW PUMP

6.3.1 CENTRIFUGAL FLOW PUMP
6.3.2 AXIAL FLOW PUMP

7 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE

7.1 INTRODUCTION
7.2 PEDIATRIC CAD
7.3 ADULT CAD

8 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 CAD TREATMENT FLOW CHART
8.3 BRIDGE TO TRANSPLANT (BTT)
8.4 BRIDGE TO DESTINATION THERAPY (BTD)
8.5 BRIDGE TO RECOVERY (BTR)
8.6 BRIDGE TO CANDIDACY (BTC)

9 REGIONAL ANALYSIS

9.1 INTRODUCTION
9.2 NORTH AMERICA

9.2.1 THE U.S.
9.2.2 REST OF NORTH AMERICA

9.3 EUROPE

9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 REST OF EUROPE

9.4 APAC

9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF APAC

9.5 ROW

9.5.1 BRAZIL
9.5.2 REST OF LATIN AMERICA
9.5.3 MIDDLE EAST AND OTHERS

10 COMPANY DEVELOPMENTS

10.1 INTRODUCTION
10.2 APPROVALS
10.3 AGREEMENTS AND JOINT VENTURES
10.4 OTHER DEVELOPMENTS

11 MAJOR COMPANIES

11.1 ABBOTT LABORATORIES

11.1.1 OVERVIEW
11.1.2 FINANCIALS
11.1.3 PRODUCT PORTFOLIO
11.1.4 KEY DEVELOPMENTS
11.1.5 BUSINESS STRATEGY
11.1.6 SWOT ANALYSIS

11.2 ABIOMED, INC.

11.2.1 OVERVIEW
11.2.2 FINANCIALS
11.2.3 PRODUCT PORTFOLIO
11.2.4 KEY DEVELOPMENTS
11.2.5 BUSINESS STRATEGY
11.2.6 SWOT ANALYSIS

11.3 BERLIN HEART GMBH

11.3.1 OVERVIEW
11.3.2 FINANCIALS
11.3.3 PRODUCT PORTFOLIO
11.3.4 KEY DEVELOPMENTS
11.3.5 BUSINESS STRATEGY
11.3.6 SWOT ANALYSIS

11.4 FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)

11.4.1 OVERVIEW
11.4.2 FINANCIALS
11.4.3 PRODUCT PORTFOLIO
11.4.4 KEY DEVELOPMENTS
11.4.5 BUSINESS STRATEGY
11.4.6 SWOT ANALYSIS

11.5 GETINGE GROUP (MAQUET)

11.5.1 OVERVIEW
11.5.2 FINANCIALS
11.5.3 PRODUCT PORTFOLIO
11.5.4 KEY DEVELOPMENTS
11.5.5 BUSINESS STRATEGY
11.5.6 SWOT ANALYSIS

11.6 LIVANOVA PLC

11.6.1 OVERVIEW
11.6.2 FINANCIALS
11.6.3 PRODUCT PORTFOLIO
11.6.4 KEY DEVELOPMENTS
11.6.5 BUSINESS STRATEGY
11.6.6 SWOT ANALYSIS

11.7 MEDTRONIC, PLC

11.7.1 OVERVIEW
11.7.2 FINANCIALS
11.7.3 PRODUCT PORTFOLIO
11.7.4 KEY DEVELOPMENTS
11.7.5 BUSINESS STRATEGY
11.7.6 SWOT ANALYSIS

11.8 SYNCARDIA SYSTEMS, LLC

11.8.1 OVERVIEW
11.8.2 FINANCIALS
11.8.3 PRODUCT PORTFOLIO
11.8.4 KEY DEVELOPMENTS
11.8.5 BUSINESS STRATEGY
11.8.6 SWOT ANALYSIS

11.9 TELEFLEX INCORPORATED

11.9.1 OVERVIEW
11.9.2 FINANCIALS
11.9.3 PRODUCT PORTFOLIO
11.9.4 KEY DEVELOPMENTS
11.9.5 BUSINESS STRATEGY
11.9.6 SWOT ANALYSIS

11.10 ZEON CORPORATION

11.10.1 OVERVIEW
11.10.2 FINANCIALS
11.10.3 PRODUCT PORTFOLIO
11.10.4 KEY DEVELOPMENTS
11.10.5 BUSINESS STRATEGY
11.10.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 2 VAD NUMBER OF UNITS SOLD, BY REGION, (2020) (NO’S)
TABLE 3 PERCUTANEOUS VAD NUMBER OF UNITS SOLD, BY REGION, (2019-2027) (NO’S)
TABLE 4 IABP NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 5 TOTAL ARTIFICIAL HEART NUMBER OF UNITS, BY REGION, (2019-2027) (NO’S)
TABLE 6 COMPANYWISE VAD NUMBER OF UNITS SOLD, (2020) (NO’S)
TABLE 7 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2019-2027) ($MN)
TABLE 8 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2019-2027) ($MN)
TABLE 9 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 10 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
TABLE 11 PARACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 12 INTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 13 PERCUTANEOUS VAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 14 LEFT VENTRICULAR ASSIST DEVICES (LVAD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 15 RIGHT VENTRICULAR ASSIST DEVICES (RVAD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 16 BI-VENTRICULAR ASSIST DEVICES (BI-VAD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 17 INTRA-AORTIC BALLOON PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 18 TOTAL ARTIFICIAL HEART GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 19 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
TABLE 20 EXTRACORPOREAL OR PARACORPOREAL CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 21 INTRACORPOREAL CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 22 PERCUTANEOUS CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 23 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 24 PULSATILE FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 25 CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 26 CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 27 CENTRIFUGAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 28 AXIAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 29 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
TABLE 30 PEDIATRIC CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 31 ADULT CAD GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 32 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 33 BRIDGE TO TRANSPLANT (BTT) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 34 BRIDGE TO DESTINATION THERAPY (BTD) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 35 BRIDGE TO RECOVERY (BTR) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 36 BRIDGE TO CANDIDACY (BTC) GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 37 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
TABLE 38 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 39 NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 40 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
TABLE 41 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 42 NORTH AMERICA CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 43 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
TABLE 44 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 45 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 46 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 47 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 48 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
TABLE 49 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 50 EUROPE CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 51 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
TABLE 52 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 53 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 54 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 55 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 56 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
TABLE 57 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 58 APAC CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 59 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
TABLE 60 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 61 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 62 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 63 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
TABLE 64 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2019-2027) ($MN)
TABLE 65 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 66 ROW CONTINUOUS FLOW PUMP MARKET REVENUE, BY PUMP TYPE, (2019-2027) ($MN)
TABLE 67 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2019-2027) ($MN)
TABLE 68 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2019-2027) ($MN)
TABLE 69 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
TABLE 70 APPROVALS, (2020-2021)
TABLE 71 AGREEMENTS AND JOINT VENTURES (2020-2021)
TABLE 72 OTHER DEVELOPMENTS (2020-2021)
TABLE 73 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 74 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2019-2021) ($MN)
TABLE 75 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 76 ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 77 ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
TABLE 78 FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 79 FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
TABLE 80 FRESENIUS MEDICAL CARE AG & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2019-2021) ($MN)
TABLE 81 GETINGE GROUP: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 82 GETINGE GROUP: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
TABLE 83 GETINGE GROUP: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 84 LIVANOVA, PLC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 85 LIVANOVA, PLC: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
TABLE 86 LIVANOVA, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 87 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 88 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2019-2021) ($MN)
TABLE 89 MEDTRONIC, PLC: CARDIAC & VASCULAR REVENUE, BY SUB-SEGMENTS, (2019-2021) ($MN)
TABLE 90 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 91 TELEFLEX INCORPORATED: TOTAL SALES AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 92 TELEFLEX INCORPORATED: TOTAL SALES, BY SEGMENTS, (2019-2021) ($MN)
TABLE 93 TELEFLEX INCORPORATED: TOTAL SALES, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 94 ZEON CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 95 ZEON CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
TABLE 96 ZEON CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)

LIST OF FIGURES

FIGURE 1 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: CARDIAC ASSIST DEVICES GLOBAL MARKET
FIGURE 3 CARDIAC ASSIST DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 CARDIAC ASSIST DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 CARDIAC ASSIST DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 CARDIAC ASSIST DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 CARDIAC ASSIST DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
FIGURE 9 CARDIAC ASSIST DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 10 U.S. PVAD MARKET PENETRATION, (2020) (%)
FIGURE 11 U.K. PVAD MARKET PENETRATION, (2020) (%)
FIGURE 12 GERMANY PVAD MARKET PENETRATION, (2020) (%)
FIGURE 13 FRANCE PVAD MARKET PENETRATION, (2020) (%)
FIGURE 14 JAPAN PVAD MARKET PENETRATION, (2020) (%)
FIGURE 15 U.S. IABP MARKET PENETRATION, (2020) (%)
FIGURE 16 U.K. IABP MARKET PENETRATION, (2020) (%)
FIGURE 17 GERMANY IABP MARKET PENETRATION, (2020) (%)
FIGURE 18 FRANCE IABP MARKET PENETRATION, (2020) (%)
FIGURE 19 JAPAN IABP MARKET PENETRATION, (2020) (%)
FIGURE 20 CARDIAC ASSIST DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 21 CARDIAC ASSIST DEVICES (CAD) GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 22 VENTRICULAR ASSIST DEVICES (VAD) GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 23 INTRA-AORTIC BALLOON PUMP (IABP) GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
FIGURE 24 CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2020 V/S 2027) (%)
FIGURE 25 VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2020 V/S 2027) (%)
FIGURE 26 CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
FIGURE 27 CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY PUMP TYPE (2020 V/S 2027) (%)
FIGURE 28 CONTINUOUS FLOW PUMP GLOBAL MARKET SHARE, BY PUMP TYPE (2020 V/S 2027) (%)
FIGURE 29 CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
FIGURE 30 CARDIAC ASSIST DEVICES GLOBAL MARKET SHARE, BY APPLICATION, (2020 V/S 2027) (%)
FIGURE 31 CAD TREATMENT FLOW CHART
FIGURE 32 CARDIAC ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%)
FIGURE 33 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 34 NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 35 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
FIGURE 36 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
FIGURE 37 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
FIGURE 38 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
FIGURE 39 NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 40 U.S. CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 41 U.S. CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 42 U.S. CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION TYPE (2020 V/S 2027) ($MN)
FIGURE 43 REST OF NORTH AMERICA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 44 REST OF NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 45 REST OF NORTH AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 46 EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 47 EUROPE VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 48 EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
FIGURE 49 EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
FIGURE 50 EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
FIGURE 51 EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
FIGURE 52 EUROPE CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 53 GERMANY CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 54 GERMANY CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 55 GERMANY CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 56 FRANCE CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 57 FRANCE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 58 FRANCE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 59 U.K. CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 60 U.K. CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 61 U.K. CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 62 REST OF EUROPE CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 63 REST OF EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 64 REST OF EUROPE CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 65 APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 66 APAC VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 67 APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE (2020 V/S 2027) (%)
FIGURE 68 APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
FIGURE 69 APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
FIGURE 70 APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
FIGURE 71 APAC CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 72 JAPAN CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES (VAD) MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 73 JAPAN CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 74 JAPAN CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 75 CHINA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES (VAD) MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 76 CHINA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 77 CHINA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION(2020 V/S 2027) ($MN)
FIGURE 78 INDIA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET (VAD) REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 79 INDIA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 80 INDIA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 81 REST OF APAC CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET (VAD) REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 82 REST OF APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 83 REST OF APAC CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 84 ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 85 ROW VENTRICULAR ASSIST DEVICES MARKET SHARE, BY PRODUCTS, (2020 V/S 2027) (%)
FIGURE 86 ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) (%)
FIGURE 87 ROW CARDIAC ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE AND CONTINUOUS FLOW PUMP TYPE (2020) ($MN)
FIGURE 88 ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY PATIENT TYPE (2020 V/S 2027) (%)
FIGURE 89 ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY APPLICATION (2020 V/S 2027) (%)
FIGURE 90 ROW CARDIAC ASSIST DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
FIGURE 91 BRAZIL CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 92 BRAZIL CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 93 BRAZIL CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 94 REST OF LATIN AMERICA CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 95 REST OF LATIN AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 96 REST OF LATIN AMERICA CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 97 MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES (CAD) AND VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS (2020 V/S 2027) ($MN)
FIGURE 98 MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2020 V/S 2027) ($MN)
FIGURE 99 MIDDLE EAST AND OTHERS CARDIAC ASSIST DEVICES MARKET REVENUE, BY APPLICATION (2020 V/S 2027) ($MN)
FIGURE 100 KEY GROWTH STRATEGIES, (2020-2021)
FIGURE 101 SWOT: ABBOTT LABORATORIES
FIGURE 102 SWOT: ABIOMED, INC.
FIGURE 103 SWOT: BERLIN HEART GMBH
FIGURE 104 SWOT: FRESENIUS MEDICAL CARE AG & CO. KGAA CARE (XENIOS AG)
FIGURE 105 SWOT: GETINGE GROUP (MAQUET)
FIGURE 106 SWOT: LIVANOVA, PLC
FIGURE 107 SWOT: MEDTRONIC, PLC
FIGURE 108 SWOT: SYNCARDIA SYSTEMS, LLC
FIGURE 109 SWOT: TELEFLEX INCORPORATED
FIGURE 110 SWOT: ZEON CORPORATION

LIST OF COMPANIES MENTIONED IN THE REPORT

1 ABBOTT LABORATORIES
2 ABIOMED, INC.
3 BALTON SP. Z O.O
4 BERLIN HEART GMBH
5 BIVACOR, INC.
6 CALON CARDIO -TECHNOLOGY LTD
7 CARDIOBRIDGE GMBH
8 CARMAT SA
9 CLEVELAND HEART, INC.
10 CORWAVE S.A.
11 EVAHEART, INC.
12 FINEHEART SARL
13 FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
14 GETINGE AB (MAQUET HOLDING)
15 GPB LIFE SCIENCE HOLDINGS LLC (INSIGHTRA MEDICAL, INC.)
16 JARVIK HEART, INC.
17 LIVANOVA, PLC (TANDEM LIFE)
18 MEDTRONIC, PLC
19 MITIHEART CORPORATION
20 OREGONHEART
21 RELIANTHEART, INC.
22 SENKO MEDICAL INSTRUMENT MFG. CO., LTD
23 SYNCARDIA SYSTEMS, LLC
24 TELEFLEX INCORPORATED
25 WINDMILL CARDIOVASCULAR SYSTEMS, INC. (WCS)
26 ZEON CORPORATION

Cardiac Assist Devices (CAD) Global Market – Forecast To 2027

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS

about IQ4I

Get in Touch

IQ4I Quality Accredit Certificate

Subscribe to Newsletter

Medical Devices

Cardiac Assist Devices (CAD) Global Market – Forecast To 2027

Cardiac Assist Devices (CAD) Global Market – Forecast To 2027

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS